BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9986857)

  • 1. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.
    Poljak M; Brencic A; Seme K; Vince A; Marin IJ
    J Clin Microbiol; 1999 Mar; 37(3):796-7. PubMed ID: 9986857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of high-risk subtypes of human papillomavirus in cervical swabs: routine use of the Digene Hybrid Capture assay and polymerase chain reaction analysis.
    Brennan MM; Lambkin HA; Sheehan CD; Ryan DD; O'Connor TC; Kealy WF
    Br J Biomed Sci; 2001; 58(1):24-9. PubMed ID: 11284220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
    Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
    Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
    Didelot MN; Boulle N; Damay A; Costes V; Segondy M
    J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
    Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
    J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid capture as a means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation.
    Callaghan J; Karim S; Mortlock S; Wintert M; Woodward N
    Br J Biomed Sci; 2001; 58(3):184-9. PubMed ID: 11575742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens.
    Um TH; Lee EH; Chi HS; Kim JW; Hong YJ; Cha YJ
    Ann Clin Lab Sci; 2011; 41(1):48-55. PubMed ID: 21325255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18.
    Shukla S; Bharti AC; Mahata S; Hussain S; Hedau S; Sharma R; Pillai MR; Krishna S; Chiplunkar S; Tongaonkar H; Das BC
    J Med Microbiol; 2010 Nov; 59(Pt 11):1303-1310. PubMed ID: 20688948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test.
    Sun XW; Ferenczy A; Johnson D; Koulos JP; Lungu O; Richart RM; Wright TC
    Am J Obstet Gynecol; 1995 Nov; 173(5):1432-7. PubMed ID: 7503181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
    Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
    Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus detection: verification with cervical cytology.
    Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA
    Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.
    Szostek S; Klimek M; Zawilinska B; Rys J; Kope J; Daszkiewic E
    Acta Biochim Pol; 2006; 53(3):603-7. PubMed ID: 17019439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2009 Aug; 31(4):208-16. PubMed ID: 19736868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.